Sign In

Press release centre

Search Press
Looking for press releases of a particular company? Enter company name (or keyword) here.

Past Press Releases - Affectis Pharmaceuticals AG

June 8, 2011
Affectis and Merck Serono announce an agreement to develop oral drugs for neurodegenerative diseases
Merck Serono to develop compounds from Affectis targeting P2X7 receptors. More

July 8, 2009
Affectis Pharmaceuticals AG Receives research grant from the State of Bavaria technology program
Affectis Pharmaceuticals announced today that it has been awarded a 550.000 grant from the Bavarian Technology Promotion Program (BayTP) of the Bavarian Ministry of Economics. More

April 6, 2009
Affectis Pharmaceuticals and Mitsubishi Tanabe Pharma enter drug discovery collaboration
Affectis Pharmaceuticals AG, a biopharmaceutical company developing innovative drugs to treat depression and schizophrenia, today announced the closing of a drug discovery collaboration agreement with Mitsubishi Tanabe Pharma Corporation (MTPC), Osaka, Japan. More

April 13, 2005
Affectis Pharmaceuticals AG Closes € 4 Million Series B Investment
Munich, Germany Affectis Pharmaceuticals AG has closed a 4 Million Series B second financing round led by EMBL Ventures, Heidelberg, Germany. Additional new investors participating in this financing round were DG Lux Multimanager I SICAV Lacuna APO BioTech, KfW, and Sunrise Water Ltd. Existing institutional investors LSP and BayernKapital as well as the Max-Planck-Society also participated. More

February 7, 2005
Affectis Pharmaceuticals AG Announces Target Validation Collaboration with Mitsubishi Pharma
Munich, Germany, Affectis Pharmaceuticals AG announced today that it has signed a collaboration agreement with Mitsubishi Pharma Corporation for the development of novel therapeutics for the treatment of affective disorders. More

February 4, 2005
Neuronova receives a silent partnership from tbg and renames to Affectis Pharmaceuticals
Neuronova AG Receives a Silent Partnership from tbg Technologie-Beteiligungs-Gesellschaft mbH and Announces Renaming to Affectis Pharmaceuticals AG More


Tech investments
From our Online Data Service
VC-backed companies
From our Radar

Recent Deals

Nov 25€24.0MInternet commerce
Feb 21€87.0MInternet services
Feb 21€18.0MInternet commerce
Feb 21€1.6MBusiness applications
Feb 20€6.0MInternet services
Feb 20€4.3MSoftware development
Feb 19€0.4MInternet commerce

For information on Europe's most extensive database on technology funding click here!


Press Releases

May 28
identiq raises $5m seed, launches privacy-first identity validation...

Apr 29
nethone raised over $1 million from innovation nest

Jan 29
yumpingo raises $10m to transform guest experiences in restaurants

Oct 1
The Link App
the link app launches version 2.0

Mar 29
Addex Therapeutics
addex sucessfully raises chf40 million in capital increase

About usContact usLegal Information
Copyright 1999-2019
Emerging Technology Research Europe Inc. All rights reserved.